L. Gou

Investigating the Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL) on Ibrutinib Therapy: Results from a Phase Ib Study

J. Byrd, I. Flinn, T. Kipps, 2021, Blood.

A Study of Novel Exploratory Tools, Digital Technologies, and Central Nervous System Biomarkers to Characterize Unipolar Depression

M. Kas, J. Praestgaard, F. Ambrosetti, 2021, Frontiers in Psychiatry.